Progression of Hematopoietic Diseases in Shanghai, China | NCT00365014

Studies
Progression of Hematopoietic Diseases in Shanghai, China

NCT00365014

Sponsor

University of Colorado, Denver

Status

Completed

Last Update Posted

Jul 23, 2013Estimated

Enrollment

10,757Actual

Phase

Not provided

Conditions

Hematologic Diseases

Interventions

Not provided

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jul 2013

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Aug 2003

Primary Completion Date

Dec 2009Actual

Completion Date

Dec 2009Actual

First Submitted Date

Aug 14, 2006

First Submission Date that Met QC Criteria

Aug 14, 2006

First Posted Date

Aug 16, 2006Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jul 19, 2013

Last Update Posted Date

Jul 23, 2013Estimated

Name	Class
Fudan University	OTHER
University of Cincinnati	OTHER
ExxonMobil Biomedical Sciences, Inc.	INDUSTRY
British Petroleum P.L.C.

Description Module

Brief Summary

Detailed Description

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility. The format for these studies is a set of clinical series superimposed on a case-control design that enables integration of detailed clinical and molecular characterizations of disease pathogenesis together with an evaluation of potential confounding and interacting factors within a structured statistical analysis of benzene exposure.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

10,757Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Blood disease patients		People with blood diseases presenting at Shanghai hospitals

Interventions

Not provided

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
blood diseases presenting at Shanghai hospitals	characterization of people with blood diseases presenting at Shanghai hospitals	hospital stay

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Men and women 18 years or older Diagnosis of hematologic abnormality

Exclusion Criteria:

Children Non hematologic diseases

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Patients with blood diseases

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Richard D Irons, PhD	University of Colorado at Denver and Health Sciences Ctr.	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Joint Sino-US Clinical and Molecular Laboratory (JCML)		Shanghai		200032	China

Condition Browse Module

MeSH Terms

ID	Term
D006402	Hematologic Diseases
D000741	Anemia, Aplastic
D009190	Myelodysplastic Syndromes
D000095542	Cytopenia
D015470	Leukemia, Myeloid, Acute
D054437	Myelodysplastic-Myeloproliferative Diseases

Ancestor Terms

ID	Term
D006425	Hemic and Lymphatic Diseases
D000740	Anemia
D000080983	Bone Marrow Failure Disorders
D001855	Bone Marrow Diseases

Browse Leaves

Not provided

Browse Branches

Not provided